drugset / Trial / NCT00427986

Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema

NCT00427986

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the present study is to examine, if retinal swelling in diabetic patients can be reduced by an intravenous injection of galactose.

Timeline

Start
2007-01
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Galactose Diagnostic / imaging agent 0.5 mg/ml Intravenous